Oxygen concentration modulates colibactin production

Gut Microbes. 2023 Jan-Dec;15(1):2222437. doi: 10.1080/19490976.2023.2222437.

Abstract

Up to 25% of the E. coli strains isolated from the feces of healthy humans harbor the pks genomic island encoding the synthesis of colibactin, a genotoxic metabolite. Evidence is accumulating for an etiologic role of colibactin in colorectal cancer. Little is known about the conditions of expression of colibactin in the gut. The intestine is characterized by a unique oxygenation profile, with a steep gradient between the physiological hypoxic epithelial surface and the anaerobic lumen, which favors the dominance of obligate anaerobes. Here, we report that colibactin production is maximal under anoxic conditions and decreases with increased oxygen concentration. We show that the aerobic respiration control (ArcA) positively regulates colibactin production and genotoxicity of pks+ E. coli in response to oxygen availability. Thus, colibactin synthesis is inhibited by oxygen, indicating that the pks biosynthetic pathway is adapted to the anoxic intestinal lumen and to the hypoxic infected or tumor tissue.

Keywords: DNA damage; Escherichia coli; colibactin; hypoxia; oxygen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Escherichia coli* / genetics
  • Gastrointestinal Microbiome*
  • Humans
  • Oxygen
  • Peptides

Substances

  • colibactin
  • Peptides
  • Oxygen

Grants and funding

This work was supported by the French Agence Nationale de la Recherche under grants ANR-17-CE35-0010, ANR-18-CE14-0039, ANR-19-CE34-0014. The hypoxystation used in this work was sponsored by a grant from INRAE (to JPN) and the European Regional Development Fund (to Dr. Nathalie Vergnolle, IRSD). CG and DL received an inter-regional“research year” scholarship (South-West France, pharmacy field).